Case number 2017-1499
Allergan Sales, LLC v. Sandoz, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | ALLERGAN SALES, LLC v. SANDOZ, INC. [OPINION] [nonprecedential] (0) |
| Apr 23, 2021 | 0 | ALLERGAN SALES, LLC v. SANDOZ, INC. [ERRATA] [nonprecedential] (0) |
| Oct 1, 2018 | 76 | The petition for writ of certiorari, [18-21], filed on 06/29/2018, was Denied on 10/01/2018. [553799] [JAB] [Entered: 10/01/2018 03:50 PM] (1) |
| Jul 5, 2018 | 75 | Petition for writ of Certiorari filed on 06/29/2018, and placed on the docket 07/03/2018, in the Supreme Court of the United States. Supreme Court #: 18-21, Allergan Sales, LLC v. Sandoz, Inc., et al. [533830] [JAB] [Entered: 07/05/2018 03:01 PM] (1) |
| Jun 26, 2018 | 74 | Notice from the Supreme Court of the United States: The application for an extension of time within which to file a petition for a writ of certiorari in the above-entitled case has been presented to the Chief Justice, who on June 22, 2018, extended the time to and including June 29, 2018. [531981] [JAB] [Entered: 06/26/2018 12:56 PM] (3) |
| Apr 4, 2018 | 73 | Mandate issued to the United States District Court for the Eastern District of Texas. Service as of this date by the Clerk of Court. [510573] [17-1499, 17-1500, 17-1558, 17-1559] [JAB] [Entered: 04/04/2018 01:06 PM] (1) |
| Mar 29, 2018 | 72 | ORDER filed denying [71] motion to stay mandate filed by Allergan Sales, LLC. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [509120] [JAB] [Entered: 03/29/2018 12:50 PM] (2) |
| Mar 28, 2018 | 71 | MOTION of Cross-Appellant Allergan Sales, LLC to stay execution of the mandate until the disposition of Plaintiff's petition for a writ of certiorari. Response/Opposition is due 04/09/2018 [Consent: opposed]. Service: 03/28/2018 by email. [508858] [17-1499]--[Edited 03/29/2018 by JAB to correct docket text] [Jonathan Singer] [Entered: 03/28/2018 05:59 PM] (25) |
| Mar 28, 2018 | 70 | ORDER filed denying [60] petition for panel rehearing filed by Allergan Sales, LLC; denying [60] petition for en banc rehearing filed by Allergan Sales, LLC. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [508564] [JAB] [Entered: 03/28/2018 10:42 AM] (2) |
| Mar 20, 2018 | 69 | 12 paper copies of the response [65] received from Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc. [506602] [JAB] [Entered: 03/20/2018 11:37 AM] (0) |
| Mar 20, 2018 | 68 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:party document Docket No. [67], ERROR: Only 6 paper copies of the response to the combined petition for panel rehearing and rehearing en banc were provided. CORRECTION: The court requires an additional 12 copies [total number required is 18 copies]. The additional paper copies should be received by the court on or before 03/22/2018. [506587] [JAB] [Entered: 03/20/2018 11:15 AM] (0) |
| Mar 20, 2018 | 67 | 6 paper copies of the response [65] received from Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc. [506583] [JAB] [Entered: 03/20/2018 11:11 AM] (0) |
| Mar 19, 2018 | 66 | Notice to counsel for Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.: The record of this case indicates that the paper copies of response to rehearing petition (see Fed. Cir. R. 35(c)(4)) have not been filed. The required paper copies should be received by the court on or before 03/21/2018. Service as of this date by the Clerk of Court. [506082] [JAB] [Entered: 03/19/2018 08:45 AM] (0) |
| Mar 12, 2018 | 65 | RESPONSE of Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc. to the petition for panel rehearing [60] filed by Cross-Appellant Allergan Sales, LLC in 17-1499 , petition for en banc rehearing [60] filed by Cross-Appellant Allergan Sales, LLC in 17-1499. Service: 03/12/2018 by email. [504319] [Sean McEldowney] [Entered: 03/12/2018 04:10 PM] (29) |
| Mar 12, 2018 | 64 | Amended Certificate of Interest for the Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.. Service: 03/12/2018 by email. [504313] [Sean McEldowney] [Entered: 03/12/2018 04:07 PM] (3) |
| Feb 26, 2018 | 63 | The court invites a response from Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc. to the petition for panel rehearing filed by Cross-Appellant in 17-1499, petition for en banc rehearing filed by Cross-Appellant in 17-1499. [500974] [SJ] [Entered: 02/26/2018 11:25 AM] (1) |
| Feb 9, 2018 | 62 | ORDER filed denying as moot motion to extend time to file petition for rehearing [59] filed by Cross-Appellant Allergan Sales, LLC. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [496757] [JAB] [Entered: 02/09/2018 03:04 PM] (2) |
| Jan 24, 2018 | 61 | 18 paper copies of the petition for panel rehearing [60], petition for en banc rehearing [60] received from Cross-Appellant Allergan Sales, LLC. [492236] [JAB] [Entered: 01/24/2018 10:17 AM] (0) |
| Jan 22, 2018 | 60 | Petition for panel rehearing, for en banc rehearing filed by Cross-Appellant Allergan Sales, LLC. Service: 01/22/2018 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 01/24/2018 [491571] [Jonathan Singer] [Entered: 01/22/2018 03:58 PM] (37) |
| Jan 12, 2018 | 59 | MOTION of Cross-Appellant Allergan Sales, LLC to extend the time to file a Petiton or Panel Rehearing until 01/29/2018. [Consent: unopposed]. Service: 01/12/2018 by email. [489428] [Susan Morrison] [Entered: 01/12/2018 03:53 PM] (5) |
| Jan 2, 2018 | 58 | ERRATUM to the Nonprecedential Opinion Doc No.: [57]. Service as of this date by Clerk of Court. [486564] [17-1499, 17-1500, 17-1558, 17-1559] [JAB] [Entered: 01/02/2018 11:36 AM] (1) |
| Dec 22, 2017 | 57 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed-in-Part and Reversed-in-Part. (Nonprecedential Opinion). (For the Court: Moore,Circuit Judge; Mayer,Circuit Judge and Hughes,Circuit Judge). [485137] [17-1499, 17-1500, 17-1558, 17-1559] [JAB] [Entered: 12/22/2017 09:53 AM] (12) |
| Oct 2, 2017 | 54 | Submitted after ORAL ARGUMENT by John C. O'Quinn for Sandoz, Inc., Alcon Laboratories, Inc. and Alcon Research, Ltd. and Jonathan Elliot Singer for Allergan Sales, LLC. Panel: Judge: Moore , Judge: Mayer , Judge: Hughes. [464633] [JAB] [Entered: 10/02/2017 10:37 AM] (0) |
| Sep 18, 2017 | 53 | Clerk's Note to the File: Oral argument will be held in Courtroom 203, rather than Courtroom 402. [461765] [JAB] [Entered: 09/18/2017 02:31 PM] (0) |
| Sep 15, 2017 | 52 | Response to oral argument order from the Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.. designating John C. O'Quinn as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [461368] [Calvin Shank] [Entered: 09/15/2017 02:27 PM] (0) |
| Sep 14, 2017 | 51 | Response to oral argument order from the Cross-Appellant Allergan Sales, LLC. designating Jonathan Singer as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [461024] [Jonathan Singer] [Entered: 09/14/2017 02:51 PM] (0) |
| Aug 21, 2017 | 50 | NOTICE OF CALENDARING. Panel: 1710H. Case scheduled Oct 02, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 402. Response to oral argument order due: 09/15/2017. Arguing counsel is required to check-in at the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [455366] [JAB] [Entered: 08/21/2017 12:48 PM] (0) |
| Jul 26, 2017 | 49 | Notice from Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc. regarding conflicts with oral argument (Argument in this case to be held during October court week; request not to schedule appeal nos. 17-1131 or 15-2021 during the same week (see letter for details)). Service: 07/26/2017 by email. [449546] [John O'Quinn] [Entered: 07/26/2017 06:12 PM] (4) |
| Jul 7, 2017 | 48 | ORDER granting motion to schedule oral argument [45] filed by Appellants Sandoz, Inc., Alcon Laboratories, Inc. and Alcon Research, Ltd.; - FOR CALENDAR. Service: 07/07/2017 by clerk. [444897] [NL] [Entered: 07/07/2017 02:09 PM] (2) |
| Jul 6, 2017 | 46 | Notice from Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc. regarding conflicts with oral argument ( Of appeal Nos. 15-2021, 17-1499, and 17-1131, request that no two be scheduled during the same argument week (see letter for details) ). Service: 07/06/2017 by email. [444333] [John O'Quinn] [Entered: 07/06/2017 12:30 AM] (2) |
| Jul 5, 2017 | 45 | MOTION of Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc. to schedule oral argument. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/05/2017 by email. [444313] [Sean McEldowney] [Entered: 07/05/2017 07:49 PM] (13) |
| Jun 16, 2017 | 44 | 6 paper copies of the Joint Appendix in 3 Volumes [41] received from Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc. [440039] [JCP] [Entered: 06/16/2017 03:21 PM] (0) |
| Jun 16, 2017 | 43 | Notice from Cross-Appellant Allergan Sales, LLC regarding conflicts with oral argument (inter partes review hearings before PTAB; trial in USDC TXED; hearing on post-trial motions in USDC-DE). Service: 06/16/2017 by email. [439970] [Jonathan Singer] [Entered: 06/16/2017 12:38 PM] (2) |
| Jun 12, 2017 | 42 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 06/19/2017. [438380] [CAB] [Entered: 06/12/2017 01:19 PM] (0) |
| Jun 6, 2017 | 38 | TENDERED from Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.. Title: JOINT APPENDIX. Service: 06/06/2017 by email. [436823] [Sean McEldowney] [Entered: 06/06/2017 03:47 PM] (2059) |
| Jun 6, 2017 | 37 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Cross-Appellant Allergan Sales, LLC. Service: 06/06/2017 by email. [436799] [Deanna Reichel] [Entered: 06/06/2017 03:14 PM] (4) |
| Jun 6, 2017 | 39 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.. Service: 06/06/2017 by email. [436826] [Sean McEldowney] [Entered: 06/06/2017 03:51 PM] (2) |
| Jun 6, 2017 | 40 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.. Service: 06/06/2017 by email. [436851] [Sean McEldowney] [Entered: 06/06/2017 04:20 PM] (2) |
| Jun 6, 2017 | 41 | JOINT APPENDIX, VOLS. I - III FILED for Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc. [38]. Number of Pages: 2,059. Service: 06/06/2017 by email. The paper copies of the brief should be received by the court on or before 06/19/2017. [438371] [CAB] [Entered: 06/12/2017 01:05 PM] (2059) |
| Jun 2, 2017 | 36 | 6 paper copies of the Reply Brief [35] received from Cross-Appellant Allergan Sales, LLC. [435967] [JCP] [Entered: 06/02/2017 01:12 PM] (0) |
| May 30, 2017 | 35 | REPLY BRIEF FILED for Cross-Appellant Allergan Sales, LLC [34]. Number of Pages: 24. Service: 05/30/2017 by email. The paper copies of the brief should be received by the court on or before 06/07/2017. Appendix is due 06/06/2017. [435317] [CAB] [Entered: 05/31/2017 12:08 PM] (32) |
| May 30, 2017 | 34 | TENDERED from Cross-Appellant Allergan Sales, LLC. Title: REPLY BRIEF. Service: 05/30/2017 by email. [435074] [Jonathan Singer] [Entered: 05/30/2017 05:05 PM] (32) |
| May 22, 2017 | 33 | 6 paper copies of the Reply Brief [31] received from Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc. [433586] [KW] [Entered: 05/23/2017 02:49 PM] (0) |
| May 18, 2017 | 32 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account of Robert M. Oakes for Allergan Sales, LLC. The e-mail address, (edocket@fr.com), associated with your CM/ECF account has generated a delivery failure notice. Counsel should promptly report a change in contact information with the Pacer Service Center (see Fed. Cir. R. 47.3(c)(1). [432433] [PMM] [Entered: 05/18/2017 08:38 AM] (0) |
| May 16, 2017 | 30 | Amended Entry of appearance for Susan E. Morrison as of counsel for Cross-Appellant Allergan Sales, LLC. Service: 05/16/2017 by email. [431995] --[Edited 05/18/2017 by clerk to correct party filer] [Susan Morrison] [Entered: 05/16/2017 03:43 PM] (1) |
| May 15, 2017 | 31 | REPLY BRIEF FILED for Appellants Alcon Laboratories, Inc., Alcon Research, Ltd., and Sandoz, Inc. [29]. Number of Pages: 68. Service: 05/15/2017 by email. The paper copies of the brief should be received by the court on or before 05/24/2017. Cross-Appellant's reply brief is due 05/30/2017. [432226] [CAB] [Entered: 05/17/2017 12:45 PM] (81) |
| May 15, 2017 | 29 | TENDERED from Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.. Title: RESPONSE BRIEF. Service: 05/15/2017 by email. [431628] [Sean McEldowney] [Entered: 05/15/2017 08:32 PM] (81) |
| Apr 18, 2017 | 28 | 6 paper copies of the Response Brief [25] received from Cross-Appellant Allergan Sales, LLC. [425139] [KW] [Entered: 04/18/2017 02:08 PM] (0) |
| Apr 13, 2017 | 27 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [423687] [JB] [Entered: 04/13/2017 08:19 AM] (0) |
| Apr 13, 2017 | 26 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Brief Docket No. [24], ERROR: cover does not follow official caption provided by clerk. Caption was revised on March 3, 2017. CORRECTION: counsel should use the official caption provided by the court in all future filings. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [423686] [JB] [Entered: 04/13/2017 08:18 AM] (0) |
| Apr 10, 2017 | 25 | BRIEF FILED for Cross-Appellant Allergan Sales, LLC [24]. Number of Pages: 70. Service: 04/10/2017 by email. The paper copies of the brief should be received by the court on or before 04/20/2017. [423684] [JB] [Entered: 04/13/2017 08:16 AM] (89) |
| Apr 10, 2017 | 24 | TENDERED from Cross-Appellant Allergan Sales, LLC. Title: OPENING BRIEF. Service: 04/10/2017 by email. [422941] [Jonathan Singer] [Entered: 04/10/2017 05:24 PM] (89) |
| Mar 9, 2017 | 23 | 6 paper copies of the Opening Brief [22] received from Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc. [414473] [KW] [Entered: 03/10/2017 02:37 PM] (0) |
| Mar 7, 2017 | 21 | Official caption revised to change party designations for Falcon Pharmaceuticals Ltd. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [413169] [CAB] [Entered: 03/07/2017 04:28 PM] (0) |
| Mar 1, 2017 | 22 | BRIEF FILED for Appellants Alcon Laboratories, Inc., Alcon Research, Ltd., and Sandoz, Inc. [20]. Number of Pages: 69. Service: 03/01/2017 by email. The paper copies of the brief should be received by the court on or before 03/14/2017. Cross-Appellant Allergan Sales, LLC brief is due 04/10/2017. [413174] [CAB] [Entered: 03/07/2017 04:34 PM] (296) |
| Mar 1, 2017 | 20 | TENDERED from Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.. Title: OPENING BRIEF. Service: 03/01/2017 by email. [411785] [Sean McEldowney] [Entered: 03/01/2017 05:47 PM] (296) |
| Feb 15, 2017 | 19 | ORDER filed. The motion [18] is granted. Appellants’ opening brief is due no later than March 1, 2017; Cross-Appellant’s response and opening brief is due no later than April 10, 2017; Appellants’ reply and response brief is due no later than May 15, 2017; and Cross-Appellant’s reply brief is due no later than May 30, 2017. Service: 02/15/2017 by clerk. [407579] [LMS] [Entered: 02/15/2017 09:47 AM] (2) |
| Feb 10, 2017 | 18 | MOTION of Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc. to set briefing schedule. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/10/2017 by email. [406674] [John O'Quinn] [Entered: 02/10/2017 05:42 PM] (5) |
| Feb 2, 2017 | 17 | Entry of appearance for Robert M. Oakes as of counsel for Cross-Appellant Allergan Sales, LLC. Service: 02/02/2017 by email. [404267] [Robert Oakes] [Entered: 02/02/2017 03:29 PM] (2) |
| Feb 2, 2017 | 16 | Entry of appearance for Susan Morrison Coletti as of counsel for Cross-Appellant Allergan Sales, LLC. Service: 02/02/2017 by email. [404265] [Susan Morrison] [Entered: 02/02/2017 03:27 PM] (2) |
| Feb 2, 2017 | 15 | Docketing Statement for the Cross-Appellant Allergan Sales, LLC. Service: 02/02/2017 by email. [404262] [Deanna Reichel] [Entered: 02/02/2017 03:24 PM] (3) |
| Feb 2, 2017 | 14 | Certificate of Interest for the Cross-Appellant Allergan Sales, LLC. Service: 02/02/2017 by email. [404260] [Deanna Reichel] [Entered: 02/02/2017 03:23 PM] (2) |
| Feb 2, 2017 | 13 | Entry of appearance for Deanna J. Reichel as of counsel for Cross-Appellant Allergan Sales, LLC. Service: 02/02/2017 by email. [404258] [Deanna Reichel] [Entered: 02/02/2017 03:23 PM] (2) |
| Feb 2, 2017 | 12 | Entry of appearance for Jonathan E. Singer as principal counsel for Cross-Appellant Allergan Sales, LLC. Service: 02/02/2017 by email. [404257] [Jonathan Singer] [Entered: 02/02/2017 03:20 PM] (2) |
| Feb 2, 2017 | 11 | Docketing Statement for the Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.. Service: 02/02/2017 by email. [404244] [John O'Quinn] [Entered: 02/02/2017 02:49 PM] (3) |
| Feb 2, 2017 | 10 | Certificate of Interest for the Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.. Service: 02/02/2017 by email. [404242] [Calvin Shank] [Entered: 02/02/2017 02:45 PM] (3) |
| Feb 2, 2017 | 9 | Entry of appearance for Bryan S. Hales as of counsel for Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.. Service: 02/02/2017 by email. [404241] [Calvin Shank] [Entered: 02/02/2017 02:44 PM] (2) |
| Feb 2, 2017 | 8 | Entry of appearance for Sean M. McEldowney as of counsel for Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.. Service: 02/02/2017 by email. [404239] [Calvin Shank] [Entered: 02/02/2017 02:43 PM] (2) |
| Feb 2, 2017 | 7 | Entry of appearance for John C. O'Quinn as principal counsel for Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.. Service: 02/02/2017 by email. [404238] [Calvin Shank] [Entered: 02/02/2017 02:42 PM] (2) |
| Feb 2, 2017 | 6 | Entry of appearance for C. Alex Shank as of counsel for Appellants Alcon Laboratories, Inc., Alcon Research, Ltd. and Sandoz, Inc.. Service: 02/02/2017 by email. [404237] [Calvin Shank] [Entered: 02/02/2017 02:40 PM] (2) |
| Feb 1, 2017 | 5 | Note to file: The following cases are associated:17-1499 Lead with 17-1500 Consolidated, and 17-1558 and 17-1559 as Cross-Appeals. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [403735] [17-1499, 17-1500, 17-1558, 17-1559] [CAB] [Entered: 02/01/2017 11:34 AM] (0) |
| Feb 1, 2017 | 4 | Official caption revised to add cross-appeals. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [403730] [CAB] [Entered: 02/01/2017 11:31 AM] (0) |
| Jan 19, 2017 | 3 | Note to file: The following cases are consolidated:17-1499 Lead with 17-1500 Consolidated member case. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [400380] [17-1499, 17-1500] [CAB] [Entered: 01/19/2017 11:52 AM] (0) |
| Jan 19, 2017 | 2 | Amended Notice of Appeal for Sandoz Inc., Alcon Laboratories Inc., Alcon Research Ltd., and Falcon Pharmaceuticals Ltd.. Service: 01/19/2017 by clerk. [400347] [CAB] [Entered: 01/19/2017 11:25 AM] (190) |
| Jan 19, 2017 | 1 | Appeal docketed. Received: 01/17/2017. [400344]Entry of Appearance due 02/02/2017. Certificate of Interest is due on 02/02/2017. Docketing Statement due 02/02/2017. Appellants' brief is due 03/20/2017. [CAB] [Entered: 01/19/2017 11:21 AM] (169) |
